Serum Separation Gel Market

By Product Type;

Serum Separation Gel Integrated with Tube, and Serum Separation Gel without Tubes

By Product;

Instruments, Reagents, and Software

By End-Users;

Hospital, Blood Bank, Pharmaceutical & Biotechnology Companies, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn261745108 Published Date: August, 2025 Updated Date: September, 2025

Serum Separation Gel Market Overview

Serum Separation Gel Market (USD Million)

Serum Separation Gel Market was valued at USD 7,871.35 million in the year 2024. The size of this market is expected to increase to USD 11,261.70 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.3%.


Serum Separation Gel Market

*Market size in USD million

CAGR 5.3 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.3 %
Market Size (2024)USD 7,871.35 Million
Market Size (2031)USD 11,261.70 Million
Market ConcentrationMedium
Report Pages379
7,871.35
2024
11,261.70
2031

Major Players

  • cardinal Health, Inc.
  • InterVacTechnologyOU
  • Becton Dickinson & Company
  • Greiner Bio One International GmbH

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Serum Separation Gel Market

Fragmented - Highly competitive market without dominant players


The Serum Separation Gel Market is experiencing strong growth driven by increasing demand for precise blood testing and diagnostic accuracy. Around 70% of clinical decisions rely on laboratory results, highlighting the crucial role of serum separation gels in ensuring high-quality sample processing. Their ability to provide reliable barrier formation between serum and clot has made them indispensable in clinical practices.

Growing Use in Healthcare and Research
The growing adoption of advanced diagnostic procedures has led to a surge in demand, with nearly 60% of hospitals and laboratories incorporating serum separation tubes in routine testing. These gels support improved efficiency in blood analysis by reducing hemolysis and contamination risks, making them vital in clinical chemistry and immunology testing.

Technological Advancements Supporting Adoption
Advancements in material science have improved the performance of serum separation gels, enhancing their stability and compatibility with automation. Reports indicate that more than 45% of new product launches in pre-analytical consumables involve improved gel formulations. This innovation trend is reshaping the market landscape by offering faster processing and more reliable results.

Enhanced Efficiency and Market Outlook
With laboratories focusing on operational efficiency, the demand for serum separation gels is expected to remain strong. Nearly 50% of laboratories have reported improved turnaround times in sample analysis after adopting high-performance gel-based solutions. The market is poised for sustained growth, fueled by innovations and expanding clinical applications.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Product
    3. Market Snapshot, By End-User
    4. Market Snapshot, By Region
  4. Serum Separation Gel Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Demand for Diagnostic Testing
        2. Increase in Chronic Disease Prevalence
        3. Technological Advancements in Laboratory Equipment
        4. Growing Awareness of Preventive Healthcare
      2. Restraints
        1. High Cost of Advanced Separation Technologies
        2. Limited Awareness Among Healthcare Providers
        3. Stringent Regulatory Requirements
        4. Variability in Product Quality and Performance
      3. Opportunities
        1. Emerging Markets for Healthcare Expansion
        2. Technological Innovations in Gel Formulations
        3. Increased Research and Development Investment
        4. Growing Demand for Point-of-Care Testing Solutions
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Serum Separation Gel Market, By Product Type, 2021 - 2031 (USD Million)
      1. Serum Separation Gel Integrated with Tube
      2. Serum Separation Gel without Tubes
    2. Serum Separation Gel Market, By Product , 2021 - 2031 (USD Million)

      1. Instruments

      2. Reagents

      3. Software

    3. Serum Separation Gel Market, By End-User, 2021 - 2031 (USD Million)
      1. Hospital, Blood Bank
      2. Pharmaceutical & Biotechnology Companies
      3. Others
    4. Serum Separation Gel Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. cardinal Health, Inc.
      2. InterVacTechnologyOU
      3. Becton Dickinson & Company
      4. Greiner Bio One International GmbH
  7. Analyst Views
  8. Future Outlook of the Market